Join to View Full Profile
2950 Cleveland Clinic BlvdWeston, FL 33331
Phone+1 877-463-2010
Dr. Thambi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2003
Rush University Medical CenterResidency, Internal Medicine, 1996 - 1999
Ohio State University College of MedicineClass of 1996
Certifications & Licensure
FL State Medical License 2024 - 2028
MD State Medical License 2003 - 2027
IL State Medical License 1996 - 2011
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification OncoEMR, Flatiron Health, Inc., 2012, 2014, 2016-2017
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jul 19
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- 14 citationsAcceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis.Yvan Beaussant, Elise Tarbi, Kabir Nigam, Skye Miner, Zachary Sager
Cancer. 2024-04-01 - 45 citationsPsilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.Manish Agrawal, William Richards, Yvan Beaussant, Sarah Shnayder, Rezvan Ameli
Cancer. 2024-04-01 - 2 citationsDeveloping a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.Robert Gramling, Emily Bennett, Keith Curtis, William Richards, Donna M Rizzo
Journal of Palliative Medicine. 2023-12-01
Press Mentions
Sunstone Therapies to Present Data on the Long-Term Efficacy of Psilocybin Therapy in Cancer Patients with Major Depressive Disorder (MDD) at the ASCO 2023 Annual MeetingMay 11th, 2023- Sunstone Therapies Collaborates with MAPS to Conduct Clinical Trial of MDMA-Assisted Therapy for PTSDSeptember 14th, 2022
- First Clinical Trial Launched to Test Psilocybin Therapy for Depression in Cancer PatientsSeptember 16th, 2020
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
